|
C18ORF8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.01820000000197E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.539730E-03 |
| Normal-vs-Stage2 |
3.522400E-02 |
| Normal-vs-Stage3 |
4.453600E-02 |
| Normal-vs-Stage4 |
8.630000E-04 |
| Stage1-vs-Stage2 |
6.255400E-01 |
| Stage1-vs-Stage3 |
6.051800E-01 |
| Stage1-vs-Stage4 |
2.018200E-01 |
| Stage2-vs-Stage3 |
4.256600E-01 |
| Stage2-vs-Stage4 |
6.259800E-01 |
| Stage3-vs-Stage4 |
1.204240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.839100E-04 |
| Normal-vs-AfricanAmerican |
4.988000E-02 |
| Normal-vs-Asian |
1.650490E-02 |
| Caucasian-vs-AfricanAmerican |
4.850800E-01 |
| Caucasian-vs-Asian |
6.129200E-01 |
| AfricanAmerican-vs-Asian |
9.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.739900E-02 |
| Normal-vs-Female |
9.32910000361886E-08 |
| Male-vs-Female |
1.049350E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.430300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.00010000000117E-05 |
| Normal-vs-Age(61-80Yrs) |
2.996200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.806300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.022200E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.820000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.135810E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.268000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.172400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.784020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.666450E-01 |
| Normal-vs-Grade 2 |
9.446400E-04 |
| Normal-vs-Grade 3 |
1.303840E-03 |
| Normal-vs-Grade 4 |
7.012400E-02 |
| Grade 1-vs-Grade 2 |
3.329600E-01 |
| Grade 1-vs-Grade 3 |
3.464000E-01 |
| Grade 1-vs-Grade 4 |
2.844000E-01 |
| Grade 2-vs-Grade 3 |
8.636400E-01 |
| Grade 2-vs-Grade 4 |
5.532800E-01 |
| Grade 3-vs-Grade 4 |
5.039800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.97000029809192E-10 |
| Normal-vs-ccB subtype |
8.600200E-01 |
| ccA subtype-vs-ccB subtype |
2.18149998065797E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.63830000000132E-05 |
| Normal-vs-N1 |
1.180630E-01 |
| N0-vs-N1 |
7.643800E-01 |
|
|
